What is HC Wainwright’s Estimate for ACRV Q1 Earnings?
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for Acrivon Therapeutics in a research note issued to investors on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates that the company will post earnings per share of ($0.63) for the quarter. HC Wainwright currently has […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for Acrivon Therapeutics in a research note issued to investors on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates that the company will post earnings per share of ($0.63) for the quarter. HC Wainwright currently has […]
